Literature DB >> 33012125

The HFA-PEFF and H2 FPEF scores largely disagree in classifying patients with suspected heart failure with preserved ejection fraction.

Sandra Sanders-van Wijk1, Arantxa Barandiarán Aizpurua1, Hans-Peter Brunner-La Rocca1, Michiel T H M Henkens1, Jerremy Weerts1, Christian Knackstedt1, Nicole Uszko-Lencer1, Stephane Heymans1,2,3, Vanessa van Empel1.   

Abstract

Entities:  

Year:  2020        PMID： 33012125     DOI： 10.1002/ejhf.2019

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  10 in total

Review 1.  Expert proposal to characterize cardiac diseases with normal or preserved left ventricular ejection fraction and symptoms of heart failure by comprehensive echocardiography.

Authors:  A Hagendorff; A Helfen; R Brandt; E Altiok; O Breithardt; D Haghi; J Knierim; D Lavall; N Merke; C Sinning; S Stöbe; C Tschöpe; F Knebel; S Ewen
Journal:  Clin Res Cardiol       Date:  2022-06-04       Impact factor: 5.460

Review 2.  Diagnostic role of echocardiography for patients with heart failure symptoms and preserved left ventricular ejection fraction.

Authors:  A Hagendorff; S Stöbe; J Kandels; R de Boer; C Tschöpe
Journal:  Herz       Date:  2022-05-02       Impact factor: 1.740

Review 3.  Heart failure with preserved ejection fraction in humans and mice: embracing clinical complexity in mouse models.

Authors:  Coenraad Withaar; Carolyn S P Lam; Gabriele G Schiattarella; Rudolf A de Boer; Laura M G Meems
Journal:  Eur Heart J       Date:  2021-11-14       Impact factor: 29.983

Review 4.  Advances in Multimodality Cardiovascular Imaging in the Diagnosis of Heart Failure With Preserved Ejection Fraction.

Authors:  Alberico Del Torto; Andrea Igoren Guaricci; Francesca Pomarico; Marco Guglielmo; Laura Fusini; Francesco Monitillo; Daniela Santoro; Monica Vannini; Alexia Rossi; Giuseppe Muscogiuri; Andrea Baggiano; Gianluca Pontone
Journal:  Front Cardiovasc Med       Date:  2022-03-09

5.  Prognostic Value of HFA-PEFF Score in Patients Undergoing Transcatheter Aortic Valve Implantation.

Authors:  Sultan Alotaibi; Karim Elbasha; Martin Landt; Jatinderjit Kaur; Arief Kurniadi; Mohamed Abdel-Wahab; Ralph Toelg; Gert Richardt; Abdelhakim Allali
Journal:  Cureus       Date:  2022-07-22

6.  Proteomic and phosphoproteomic profiling in heart failure with preserved ejection fraction (HFpEF).

Authors:  María Valero-Muñoz; Eng Leng Saw; Ryan M Hekman; Benjamin C Blum; Zaynab Hourani; Henk Granzier; Andrew Emili; Flora Sam
Journal:  Front Cardiovasc Med       Date:  2022-08-25

7.  Non-invasive assessment of HFpEF in mouse models: current gaps and future directions.

Authors:  María Villalba-Orero; Pablo Garcia-Pavia; Enrique Lara-Pezzi
Journal:  BMC Med       Date:  2022-10-14       Impact factor: 11.150

8.  Diving Into the Diagnostic Score Algorithms of Heart Failure With Preserved Ejection Fraction.

Authors:  Dmitry Abramov; Purvi Parwani
Journal:  Front Cardiovasc Med       Date:  2021-06-10

9.  Improving diagnosis and risk stratification across the ejection fraction spectrum: the Maastricht Cardiomyopathy registry.

Authors:  Michiel T H M Henkens; Jerremy Weerts; Job A J Verdonschot; Anne G Raafs; Sophia Stroeks; Maurits A Sikking; Hesam Amin; Sanne G J Mourmans; Chrit B G Geraeds; Sandra Sanders-van Wijk; Arantxa Barandiarán Aizpurua; Nicole H M K Uszko-Lencer; Ingrid P C Krapels; Petra F G Wolffs; Han G Brunner; Rick E W van Leeuwen; Wouter Verhesen; Simon M Schalla; Antonius W M van Stipdonk; Christian Knackstedt; Xiaofei Li; Myrurgia A Abdul Hamid; Pieter van Paassen; Mark R Hazebroek; Kevin Vernooy; Hans-Peter Brunner-La Rocca; Vanessa P M van Empel; Stephane R B Heymans
Journal:  ESC Heart Fail       Date:  2022-02-04

Review 10.  Cyclic GMP modulating drugs in cardiovascular diseases: mechanism-based network pharmacology.

Authors:  Alexandra Petraina; Cristian Nogales; Thomas Krahn; Hermann Mucke; Thomas F Lüscher; Rodolphe Fischmeister; David A Kass; John C Burnett; Adrian J Hobbs; Harald H H W Schmidt
Journal:  Cardiovasc Res       Date:  2022-07-20       Impact factor: 13.081
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.